跳至主要内容
临床试验/NCT07305935
NCT07305935已完成不适用

Comparative Efficacy of Early Caffeine Administration Versus Supportive Therapy in Preventing Acute Kidney Injury in Preterm Neonates

Muhammad Aamir Latif2 个研究点 分布在 1 个国家目标入组 236 人开始时间: 2025年10月1日最近更新:
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
236
试验地点
2
主要终点
Acute Kidney Injury

研究概览

简要总结

Recent observational data point towards a reduced incidence of acute kidney injury (AKI) with early caffeine use, but high-quality randomized controlled trials comparing early caffeine initiation to supportive therapy alone are lacking. This study aims to fill this critical gap by comparing the efficacy of early caffeine administration versus supportive therapy in preventing AKI in preterm neonates.

详细描述

There remains a debate about whether early initiation of caffeine therapy reduces the incidence and severity of AKI in preterm neonates compared to standard supportive care or not. Therefore, the incidence of AKI in preterm neonates will be compared between those receiving early caffeine therapy versus those receiving standard supportive therapy. The findings of this study would not only be a valuable addition to the statistics but also help clinicians to go for a better option in preterm neonates to prevent AKI, resulting in reducing the duration of mechanical ventilation, length of hospital stays, and all-cause neonatal mortality.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
1 Hour 至 6 Hours(Child)
性别
All
接受健康志愿者

入选标准

  • Neonates of any gender
  • Neonates with gestational age <32 weeks
  • Admitted within 6 hours of birth

排除标准

  • Major congenital anomalies
  • Severe birth asphyxia (Apgar <3 at 10 min)
  • Pre-existing renal anomalies

研究组 & 干预措施

Supportive Care Group

Experimental

Neonates will be given supportive care without caffeine

干预措施: Supportive care (Drug)

Early Caffeine Group

Experimental

Neonates will receive caffeine citrate (IV or enteral) in 20 mg/kg loading dose within 24 hours of life, followed by a 5 mg/kg/day maintenance dose.

干预措施: Caffeine (Drug)

结局指标

主要结局

Acute Kidney Injury

时间窗: 14 days

Incidence of AKI within the first 14 days of life.

次要结局

  • Duration of Acute Kidney Injury(Up to 30 days)
  • Length of Hospital Stay(Up to 30 days)
  • Mortality(Up to 30 days)

研究者

发起方
Muhammad Aamir Latif
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Muhammad Aamir Latif

Research Consultant

RESnTEC, Institute of Research

研究点 (2)

Loading locations...

相似试验